Literature DB >> 16227549

Tuberculous meningitis in BCG vaccinated and unvaccinated children.

R Kumar1, A Dwivedi, P Kumar, N Kohli.   

Abstract

BACKGROUND: A modified clinical presentation of tuberculous meningitis (TBM) in children vaccinated with BCG has been described in the literature. However, most reports are old and not based on actual comparisons and tests of significance. Also, neuroimaging features were not compared. With large scale BCG coverage, it becomes pertinent to describe the "modified" presentation and identify any significant differences between vaccinated and unvaccinated children with TBM.
METHODS: A total of 150 consecutive hospitalised children (96 unvaccinated, 54 vaccinated) were enrolled. They all satisfied predefined criteria for diagnosis of TBM. Clinical and radiological features of children with/without a BCG scar were compared.
RESULTS: Univariate analysis revealed that the vaccinated children with TBM had significantly lower rates of altered sensorium (68.5% v 85.4% unvaccinated; OR 2.2 (1.1 to 6.2); p = 0.019) and focal neurological deficits (20.3% v 39.5% unvaccinated; OR 2.6 (1.1 to 6.0); p = 0.016), and higher mean (SD) Glasgow Coma Scale score (10.2 (3.4) v 8.76 (2.7) unvaccinated; p = 0.010) and cerebrospinal fluid cell count (210.9 v 140.9 unvaccinated; p = 0.019). No significant radiological differences were seen. Short term outcome was significantly better in the vaccinated group with 70% of the total severe sequelae and 75% of the total deaths occurring in the unvaccinated group (p = 0.018).
CONCLUSION: Children with TBM who have been vaccinated with BCG appear to maintain better mentation and have a superior outcome. This may in part be explained by the better immune response to infection, as reflected in the higher CSF cell counts in this group in the present study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227549      PMCID: PMC1739405          DOI: 10.1136/jnnp.2005.065201

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Tuberculosis in BCG vaccinated and unvaccinated children.

Authors:  P Chandra
Journal:  Indian Pediatr       Date:  1975-05       Impact factor: 1.411

2.  [Changes of the tuberculosis of the central nervous system since the introduction of prophylactic BCG vaccination and tuberculostatic therapy (author's transl)].

Authors:  B Weigel
Journal:  Zentralbl Allg Pathol       Date:  1976

3.  Evaluation of BCG vaccination among Puerto Rican children.

Authors:  G W Comstock; V T Livesay; S F Woolpert
Journal:  Am J Public Health       Date:  1974-03       Impact factor: 9.308

4.  Tuberculosis studies in Muscogee County, Georgia. VII. A twenty-year evaluation of BCG vaccination in a school population.

Authors:  G W Comstock; R G Webster
Journal:  Am Rev Respir Dis       Date:  1969-12

5.  High resolution air CT meatography: the demonstration of normal and abnormal structures in the cerebello-pontine cistern and internal auditory meatus.

Authors:  P D Phelps; G A Lloyd
Journal:  Br J Radiol       Date:  1982-01       Impact factor: 3.039

6.  A study of tuberculosis in BCG vaccinated children.

Authors:  B Bhandari; S L Mandowara
Journal:  Indian Pediatr       Date:  1982-10       Impact factor: 1.411

7.  Tuberculosis in BCG vaccinated children.

Authors:  A Parthasarathy; R Narmada; K A Krishnamoorthy
Journal:  Indian Pediatr       Date:  1982-09       Impact factor: 1.411

8.  Protective value of BCG vaccine.

Authors:  P M Udani
Journal:  Indian Pediatr       Date:  1982-09       Impact factor: 1.411

9.  Experimental tuberculosis of the central nervous system.

Authors:  P N Tandon; B Singh; L N Mohapatra; M Kumar; S Das
Journal:  Neurol India       Date:  1970-06       Impact factor: 2.117

10.  BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.

Authors:  P D Hart; I Sutherland
Journal:  Br Med J       Date:  1977-07-30
View more
  7 in total

1.  Tuberculous meningitis: more evidence for protective effect of BCG.

Authors:  M A Anjay; P Anoop
Journal:  Arch Dis Child       Date:  2007-03       Impact factor: 3.791

2.  Morphine alters M. bovis infected microglia's ability to activate γδ T lymphocytes.

Authors:  Michael Olin; Keumhwa Choi; Thomas W Molitor
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-01       Impact factor: 4.147

Review 3.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

4.  Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study.

Authors:  Nguyen Duc Bang; Maxine Caws; Thai Thanh Truc; Tran Ngoc Duong; Nguyen Huy Dung; Dang Thi Minh Ha; Guy E Thwaites; Doortje Heemskerk; Joel Tarning; Laura Merson; Pham Van Toi; Jeremy J Farrar; Marcel Wolbers; Thomas Pouplin; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2016-10-18       Impact factor: 3.090

5.  Tubercular meningitis in children: Clinical, pathological, and radiological profile and factors associated with mortality.

Authors:  Anil V Israni; Divya A Dave; Anirban Mandal; Amitabh Singh; Puneet K Sahi; Rashmi Ranjan Das; Arpita Shah
Journal:  J Neurosci Rural Pract       Date:  2016 Jul-Sep

Review 6.  Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.

Authors:  Rodrigo Abreu; Pramod Giri; Fred Quinn
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

Review 7.  Tuberculous meningitis in children: Clinical management & outcome.

Authors:  Bella Devaleenal Daniel; G Angeline Grace; Mohan Natrajan
Journal:  Indian J Med Res       Date:  2019-08       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.